HSTCOTCPharmaceutical PreparationsFiscal year ends December 31
HST Global, Inc.
Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-K on Nov 3, 2025
$0.70+0.57 (+423.56%)
Close on Oct 19, 2026
- Market cap
- $28.78M
- P/E (TTM)
- –
- Dividend yield
- –
HST Global, Inc. income statement
Ratios
Latest available, balances at Sep 30, 2024
Profitability, TTM
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2023
- 28.2%
Financial strength
- Current ratio
- 0.25
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 24.7%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 23.23
- Dividend yield
- –